Found: 65
Select item for more details and to access through your institution.
Synthesis of <sup>18</sup>F‐labeled Aryl Trifluoromethyl Sulfones, ‐Sulfoxides, and ‐Sulfides for Positron Emission Tomography.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 27, p. 1, doi. 10.1002/ange.202404278
- By:
- Publication type:
- Article
Synthesis of <sup>18</sup>F‐labeled Aryl Trifluoromethyl Sulfones, ‐Sulfoxides, and ‐Sulfides for Positron Emission Tomography.
- Published in:
- Angewandte Chemie International Edition, 2024, v. 63, n. 27, p. 1, doi. 10.1002/anie.202404278
- By:
- Publication type:
- Article
Improving Routine <sup>89</sup>Zr‐Immuno‐PET Applications: Mild Iron Removal Can Favor the Use of Fe‐DFO‐N‐suc‐TFP Ester Over p‐NCS‐Bz‐DFO.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 8, p. 280, doi. 10.1002/jlcr.4097
- By:
- Publication type:
- Article
[11C]CO2 BOP fixation with amines to access 11C‐labeled ureas for PET imaging.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 6, p. 201, doi. 10.1002/jlcr.4075
- By:
- Publication type:
- Article
Synthesis and preclinical evaluation of [<sup>11</sup>C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.
- Published in:
- EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01078-6
- By:
- Publication type:
- Article
Non-specific irreversible <sup>89</sup>Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using <sup>89</sup>Zr-immuno-PET.
- Published in:
- EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01079-5
- By:
- Publication type:
- Article
How to obtain the image-derived blood concentration from <sup>89</sup>Zr-immuno-PET scans.
- Published in:
- EJNMMI Physics, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40658-024-00621-7
- By:
- Publication type:
- Article
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-023-00610-6
- By:
- Publication type:
- Article
89 Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5546, doi. 10.3390/cancers15235546
- By:
- Publication type:
- Article
State of the art procedures towards reactive [<sup>18</sup>F]fluoride in PET tracer synthesis.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00203-5
- By:
- Publication type:
- Article
Validation of simplified uptake measures against dynamic Patlak K<sub>i</sub> for quantification of lesional <sup>89</sup>Zr-Immuno-PET antibody uptake.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 1897, doi. 10.1007/s00259-023-06151-1
- By:
- Publication type:
- Article
<sup>89</sup>Zr-immuno-PET using the anti-LAG-3 tracer [<sup>89</sup>Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 2068, doi. 10.1007/s00259-023-06164-w
- By:
- Publication type:
- Article
Preclinical Evaluation of <sup>89</sup>Zr-Desferrioxamine-Bexmarilimab, a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, in a Rabbit Model of Renal Fibrosis.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 555, doi. 10.2967/jnumed.122.264725
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 12, p. 1880, doi. 10.2967/jnumed.121.263330
- By:
- Publication type:
- Article
<sup>89</sup>Zr-labeled High-Density Lipoprotein Nanoparticle PET imaging reveals tumor uptake in patients with esophageal cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263330
- By:
- Publication type:
- Article
Advancing <sup>89</sup>Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody -- The choice of chelator is essential.
- Published in:
- Theranostics, 2022, v. 12, n. 16, p. 7067, doi. 10.7150/thno.73509
- By:
- Publication type:
- Article
<sup>89</sup>Zr-labeled High-Density Lipoprotein Nanoparticle PET imaging reveals tumor uptake in patients with esophageal cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263330
- By:
- Publication type:
- Article
<sup>89</sup>Zr-labeled High-Density Lipoprotein Nanoparticle PET imaging reveals tumor uptake in patients with esophageal cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263330
- By:
- Publication type:
- Article
PET‐CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients.
- Published in:
- Advanced Materials, 2022, v. 34, n. 21, p. 1, doi. 10.1002/adma.202201043
- By:
- Publication type:
- Article
The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 4, p. N.PAG, doi. 10.3390/ph15040450
- By:
- Publication type:
- Article
Immuno-PET Imaging of Atherosclerotic Plaques with [ 89 Zr]Zr-Anti-CD40 mAb—Proof of Concept.
- Published in:
- Biology (2079-7737), 2022, v. 11, n. 3, p. 408, doi. 10.3390/biology11030408
- By:
- Publication type:
- Article
Towards PET imaging of the dynamic phenotypes of microglia.
- Published in:
- Clinical & Experimental Immunology, 2021, v. 206, n. 3, p. 282, doi. 10.1111/cei.13649
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small- cell lung cancer . .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
Evaluating N‐difluoromethyltriazolium triflate as a precursor for the synthesis of high molar activity [<sup>18</sup>F]fluoroform.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2021, v. 64, n. 12, p. 466, doi. 10.1002/jlcr.3939
- By:
- Publication type:
- Article
First-in-human study of<sup> 89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
In memoriam: Marion Hendriks-de Jong.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing mice.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00799-2
- By:
- Publication type:
- Article
Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 3, p. 694, doi. 10.1007/s00259-020-05002-7
- By:
- Publication type:
- Article
The navigating and de-risking role of <sup>89</sup>Zr-immuno-PET in the development of biopharmaceuticals.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.239558
- By:
- Publication type:
- Article
PET imaging of P2X<sub>7</sub>R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [<sup>11</sup>C]SMW139.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Design, Synthesis, Radiosynthesis and Biological Evaluation of Fenretinide Analogues as Anticancer and Metabolic Syndrome‐Preventive Agents.
- Published in:
- ChemMedChem, 2020, v. 15, n. 16, p. 1579, doi. 10.1002/cmdc.202000143
- By:
- Publication type:
- Article
Synthesis of [<sup>18</sup>F]Fluoroform with High Molar Activity.
- Published in:
- European Journal of Organic Chemistry, 2020, v. 2020, n. 9, p. 1177, doi. 10.1002/ejoc.202000056
- By:
- Publication type:
- Article
The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 2, p. 379, doi. 10.1007/s00259-019-04550-x
- By:
- Publication type:
- Article
ImmunoPET imaging to assess target engagement: Experience from 89Zr‐anti‐HER3 mAb (GSK2849330) in patients with solid tumors.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.214726
- By:
- Publication type:
- Article
Immuno-PET Imaging to Assess Target Engagement: Experience from <sup>89</sup>Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 7, p. 902, doi. 10.2967/jnumed.118.214726
- By:
- Publication type:
- Article
The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0514-9
- By:
- Publication type:
- Article
Fully Automated <sup>89</sup>Zr Labeling and Purification of Antibodies.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 5, p. 691, doi. 10.2967/jnumed.118.217158
- By:
- Publication type:
- Article
The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2019, v. 4, n. 1, p. 1, doi. 10.1186/s41181-019-0055-6
- By:
- Publication type:
- Article
Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PET Imaging of Microglial Activation—Beyond Targeting TSPO.
- Published in:
- Molecules, 2018, v. 23, n. 3, p. 607, doi. 10.3390/molecules23030607
- By:
- Publication type:
- Article
Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0358-8
- By:
- Publication type:
- Article